Crescita Therapeutics Inc.
CTX.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -220.60K | -35.90K | 358.40K | -947.90K | -2.20M |
| Total Depreciation and Amortization | 1.11M | 1.07M | 1.04M | 990.60K | 957.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -140.70K | -376.90K | -571.50K | 8.70K | 144.50K |
| Change in Net Operating Assets | 504.40K | 128.60K | 647.60K | 882.80K | 2.44M |
| Cash from Operations | 1.25M | 790.40K | 1.48M | 934.30K | 1.34M |
| Capital Expenditure | -768.50K | -801.60K | -1.02M | -1.03M | -1.57M |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 57.20K | 57.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.90K | 96.80K | -- | -- | -- |
| Cash from Investing | -633.50K | -704.70K | -1.02M | -973.90K | -1.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -457.00K | -515.00K | -463.00K | -455.00K | -449.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -180.00K | -223.00K | -300.00K | -296.00K | -285.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -50.00K | -50.00K | -50.00K | -50.00K |
| Cash from Financing | -495.90K | -565.00K | -582.20K | -575.10K | -564.10K |
| Foreign Exchange rate Adjustments | 2.30K | -5.70K | 42.90K | 22.40K | 29.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.70K | -485.00K | -81.50K | -592.30K | -715.70K |